Entries by weberfr8

Listening to the CML patient community

Listening to the CML patient community
weberfr8
Tue, 02/13/2024 – 09:08

Read more about Listening to the CML patient community
PrintPDF

How collaboration can enhance your science career

How collaboration can enhance your science career
weberfr8
Wed, 02/07/2024 – 09:13

Read more about How collaboration can enhance your science career
PrintPDF

Innovation fueled by compassion

Innovation fueled by compassion
weberfr8
Fri, 12/08/2023 – 17:11

Read more about Innovation fueled by compassion
PrintPDF

Shoulder to shoulder

Shoulder to shoulder
weberfr8
Sat, 12/02/2023 – 14:26

Read more about Shoulder to shoulder
PrintPDF

Our next era

Our next era
weberfr8
Thu, 11/30/2023 – 14:03

Read more about Our next era
PrintPDF

Beacon of Hope lights the way for a more equitable future

Beacon of Hope lights the way for a more equitable future
weberfr8
Wed, 11/22/2023 – 08:44

Read more about Beacon of Hope lights the way for a more equitable future
PrintPDF

Novartis Financial Results – Q3 2023

Novartis Financial Results – Q3 2023
weberfr8
Fri, 10/20/2023 – 14:36

Read more about Novartis Financial Results – Q3 2023
PrintPDF

Novartis condemns the terrorist actions against people in Israel and loss of innocent lives

Novartis condemns the terrorist actions against people in Israel and loss of innocent lives
weberfr8
Fri, 10/13/2023 – 13:02

Read more about Novartis condemns the terrorist actions against people in Israel and loss of innocent lives
PrintPDF

Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.

Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
weberfr8
Tue, 09/19/2023 – 14:30

Read more about Novartis statement on collaboration and license agreement for tislelizumab with BeiGene, Ltd.
PrintPDF